Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal
Germany-based Evotec SE (NASDAQ:EVO) is trading on Monday after a report that suggests the company is a takeover target. The ...
Evotec soars on Triton's near 10% stake, report it weighs buyout bid
Shares in Evotec jumped as much as 13.3% on Monday after regulatory filings showed private equity firm Triton had built an over 9% stake in the German drug development company.
Evotec rallies after Bloomberg says Triton weighing takeover bid
Triton Partners, is considering a takeover bid Evotec , Eyk Henning of Bloomberg reported earlier, citing people familiar with the matter. Triton is among several investment firms ...
FierceBiotech3d
Evotec, after stock-tanking blows, attracts private equity buyout interest: report
Evotec’s struggles have put it in the crosshairs of private equity groups. After seeing the company’s share price fall around ...
Evotec Shares Jump After Triton Acquires Stake
Evotec shares soared after the company said private equity group Triton had acquired about 10% of its stock. Luxembourg-based private equity firm Triton acquired a total of 17,730,913 ordinary shares ...
Yahoo Finance3d
Triton Weighs Takeover Deal for Drug Developer Evotec
(Bloomberg) -- Triton Partners is considering a takeover bid for Germany’s Evotec SE, according to people familiar with the matter, after the private equity firm emerged as one of the drug developer’s ...
Evotec shares jump as Triton becomes biggest shareholder with near 10% stake
Evotec confirmed to Reuters that Triton now holds a 9.99% stake in the company, making it its biggest shareholder, but said this had no impact on its day-to-day operations. Triton raised its stake to ...
Evotec surges on report Triton Partners evaluating takeover (Update)
Updates shares, adds further details. Evotec SE (NASDAQ:EVO) ADRs surged 18% after a report that Triton Partners is considering a takeover offer for the German drug developer. Triton is among one of ...
STAT2d
Pharmalittle: We’re reading about 23andMe retrenching, AstraZeneca reworking cancer drug plans, and more
In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...
Europe's STOXX 600 jumps on defence stocks prospects, data in focus
European shares opened higher on Monday with most sectors rising, kicking off a week packed with global economic data ...
Evotec surges as Triton said to consider takeover
Evotec surged on Monday as it emerged that private equity firm Triton Partners is considering a takeover bid for the German drug development company after taking a near-10% stake.
Europe midday: Stoxx rally continues; Evotec surges as Triton takes stake
European shares maintained gains on Monday as the post-US election rally continued, while Evotec shares surged on a report that private equity outfit Triton was mulling a bid for the German drug ...